Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vilanterol, a Novel Inhaled Long-Acting β-Agonist, in Children Aged 5–11 Years with Persistent Asthma: A Randomized Trial

This multi-center, randomized, double-blind, placebo-controlled, two-way crossover study was designed to characterize the safety, tolerability, pharmacokinetic, and pharmacodynamic profile of single and once-daily repeat doses of vilanterol 25 µg in children aged 5–11 years. Twenty-eight children wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliver, Amanda, VanBuren, Sandi, Allen, Ann, Hamilton, Melanie, Tombs, Lee, Kempsford, Rodger, Qaqundah, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467260/
https://www.ncbi.nlm.nih.gov/pubmed/26097789
http://dx.doi.org/10.1002/cpdd.92

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467260/
https://www.ncbi.nlm.nih.gov/pubmed/26097789
http://dx.doi.org/10.1002/cpdd.92

Ejemplares similares